Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. - Wikidata - wikimedia - TriplyDB

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

http://www.wikidata.org/entity/Q37606175

about

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion Lymphovascular space invasion in robotic surgery for endometrial cancer.Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer.Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Significance of lymphovascular space invasion in epithelial ovarian cancer.The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence.The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer.Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients.The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype.Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.Update on prognostic markers for endometrial cancer.Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma.Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma.Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma.Risk factors for paraaortic lymph node metastasis in endometrial cancer.Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.Identification of microRNA expression profile related to lymph node status in women with early-stage grade 1-2 endometrial cancer.Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.The Impact of Lymphovascular Space Invasion on Recurrence and Survival in Iranian Patients With Early Stage Endometrial Cancer.ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion.Metastatic uterine tumor resembling ovarian sex cord tumor: A case report and review of the literature Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.Type of vascular invasion in association with progress of endometrial cancer.The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.The evaluation of reliability and contribution of frozen section pathology to staging endometrioid adenocarcinomas.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

P2860

Q33683007-6C16C1F1-D6FC-4268-B1AB-DA03B818D8BD Q34132421-903B3CE9-8ABD-41B6-8DD3-A9A9824D8614 Q34219967-9F47A998-2025-415D-9D17-454B039A1E76 Q34996976-DD385C00-3AAE-4C0B-A6BA-DFD688B14357 Q35672819-CA0B6ACD-879A-4B6B-A6D2-099B49E5629E Q35995390-01DD52A9-4544-4BD0-8222-4DD905FC4E75 Q36120982-47CF4323-9D76-485B-9937-0379FD90CD95 Q36205599-5AB3381E-FF03-4D64-A856-9FA9C50ABC37 Q36372293-3E7B0B17-1EAF-4EAC-B69D-E112F7DBE04A Q36530725-292710CD-E7C8-46AE-8AB3-2F79C431035E Q36750961-9A00108F-712C-4703-8A5C-819E4EF9A6E7 Q36764919-55641AFD-8E91-4CB8-8636-880A6FE5DF3E Q37209603-85432395-D5B6-496E-B207-033B0596E265 Q37248787-37FBDA0D-433A-4EA2-9B49-8106636FC7A5 Q37288075-24419EDA-8E43-4ABD-A108-EA3E373E7DEA Q37486143-363482DC-3F30-4873-9BC5-220A58B049D4 Q37530703-C33E4316-D73C-41CC-8C55-E08F34FCBDCB Q37662462-F9624DD8-2B45-4748-B674-2F167200F250 Q38222517-49373103-40A3-4EAB-88EE-BF9AF90C42E8 Q38372474-19FA3418-54B8-4260-9D06-CC4E481EC8A7 Q38628862-49CCA615-E490-43C4-B92A-B8EFF1A6D90C Q38678448-C952E67B-BA7D-40AB-82FD-6AA55AC27D46 Q38775554-187E3AB5-AF1C-4D3B-B810-AA9F0F75390F Q39021988-85A7C324-A4BD-4643-98AC-E8F8C76E7339 Q40928879-7F6D9FC2-9F89-4158-A817-95177E47E583 Q41338527-EADB6A2B-C61E-44A1-8114-47809EF3D6EC Q41864261-2C80E3E4-83D9-44B5-99EF-49846D2E18C6 Q41895152-C75D9608-BD6D-403B-9645-24F184A4426B Q42373451-31ACD54E-46F8-489D-9BC3-61560BBFCC59 Q42700307-89FB3352-E1AB-4D23-88CE-DAC63BB84784 Q44515920-54BCD94B-906D-4911-A63D-359FAFA4C86C Q48351320-61734414-090F-4F4B-9DBA-75A5B3AFBB34 Q49629358-BD76F7A5-4738-46DA-BD36-482D8D197AEF Q50765383-E32BED45-9535-4790-B9F3-2B77965C1345 Q53076176-A5BF4D84-659D-4400-9008-D4A3FB118266 Q53638775-7B6F2858-2D04-4410-AACD-E8E634043484 Q57903637-FA7E9E7E-71A0-47F8-A3A0-9A8B0266DEEA

P2860

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

http://www.wikidata.org/entity/Q37606175

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@en

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@nl

type

label

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@en

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@nl

prefLabel

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@en

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@nl

P1433

Q37606175-7104E1B2-2FD7-4CC6-A35B-740D4AE5FDEE

P1476

Q37606175-3676510C-C47D-4DC9-80B8-84FA65ABD6F7

P2093

Q37606175-02033C28-2722-4639-B538-CE6F69E71EA5

Q37606175-3277EACB-C081-4D83-BA61-E41B54C3D00E

Q37606175-58250860-6BDB-4106-927C-C84DF18246EF

Q37606175-9DC2540F-210F-42C6-A678-CAD5ED5C8AF3

Q37606175-A6D6C9D9-ABA0-4E3E-8DB0-038187FF8A2F

Q37606175-CBD71D26-A6AD-4A81-A9D3-A6776A8CE3DC

Q37606175-EA7E5B2B-60B1-4150-962B-DD66C143D851

Q37606175-F5115F9B-6843-4797-B63C-A0DDFD59045C

P2860

Q37606175-2607DDC1-3F0E-4127-A124-FF4161620AFF

Q37606175-2A925D1C-4EA2-43D1-9495-13BFAF202BAA

Q37606175-409A830F-A648-450A-B51F-87D986D1B97F

Q37606175-62BF8C75-0127-44A6-8229-B1DDECEC3BF6

Q37606175-6343A1E9-25A1-4384-AB9C-D7759DF94F06

Q37606175-6867925A-BC1B-4EF7-8FF1-580D93372629

Q37606175-94CE0AC4-543B-42B5-8639-DAA62FF9DFEB

Q37606175-B77936AE-2282-4BFA-8D10-95FB727DD931

Q37606175-BB43D422-ED60-4D8D-B2A5-5237A95673C9

Q37606175-BECC82CC-6560-4397-A1E4-CA73FC8155EC

P304

Q37606175-23CBED7F-EB7A-4D50-9B15-9E677B793DE5

P31

Q37606175-34F87563-55E2-4762-A9D6-F2BE415C0B70

P3181

Q37606175-5927C1E5-7D9D-4DD9-8E47-8AC9E3666A1E

P356

Q37606175-087A32A1-5B54-4C61-BFAD-CE209239F7D6

P407

Q37606175-9F682C88-2AEE-4F5B-B7B9-8C73BAB5DCE7

P433

Q37606175-98DD4C16-D789-4A80-B67D-6DDCB69F0721

P478

Q37606175-D1861FFE-F15D-45CD-9C3E-937DBC6CD5B6

P577

Q37606175-B4FBEF72-ABE8-4E24-BAE2-CA45FF2C3CF1

P698

Q37606175-F9AE0572-D4B6-4EB4-BFCF-9AE6F28A1EE6

P921

Q37606175-BD78390C-B39A-4E1C-8C6C-E1FD40E0EFC2

P932

Q37606175-C257B38F-9A6D-45C9-BF86-52A48FF250B4

P3181

P356

J.YGYNO.2011.09.017

P1433

Gynecologic Oncology

P1476

Lymphovascular space invasion ...... dometrioid endometrial cancer.

@en

P2093

David G Mutch

http://www.w3.org/2001/XMLSchema#string

Israel Zighelboim

http://www.w3.org/2001/XMLSchema#string

Matthew A Powell

http://www.w3.org/2001/XMLSchema#string

Nora T Kizer

http://www.w3.org/2001/XMLSchema#string

Paul J Goodfellow

http://www.w3.org/2001/XMLSchema#string

Premal H Thaker

http://www.w3.org/2001/XMLSchema#string

Qin Zhang

http://www.w3.org/2001/XMLSchema#string

Saketh R Guntupalli

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients.

Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva.

Influence of gynecologic oncologists on the survival of patients with endometrial cancer.

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

P304

31-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

346

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.YGYNO.2011.09.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22030404

http://www.w3.org/2001/XMLSchema#string

P921

P932

3936402

http://www.w3.org/2001/XMLSchema#string